Safety

News

In his maiden speech as HHS Secretary, RFK Jr said he will investigate the role of childhood vaccines and other 'taboo' topics in chronic disease.

News

Shares in Pliant plunged after the US biotech revealed that a safety signal led it to pause a trial of its idiopathic pulmonary fibrosis drug.

News

It seems Eisai and Biogen have another hurdle to jump over in their bid to get EU approval for their Alzheimer's disease therapy Leqembi.

News

The largest observational study of GLP-1 weight-loss drugs suggests their benefits could be wide-ranging, but there are some risks to consider.

News

The FDA has banned the use of a red dye used in oral medicines, foods and dietary supplements, more than 30 years after it was linked to cancer.

News

Adverse events have led Keros to abandon a phase 2 trial of pulmonary arterial hypertension drug cibotacept, a would-be rival to MSD's Winrevair.